Related Experiment Video
Updated: May 14, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Massimo Filippi1, Paolo Preziosa, Maria A Rocca
1Neuroimaging Research Unit and Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, via Olgettina, 60, 20132 Milan, Italy. filippi.massimo@hsr.it
Abstract:
A combination of genetic and environmental factors probably plays a role in determining an increased susceptibility to multiple sclerosis (MS). Among these factors, vitamin D and A metabolites are likely to play a role given their immunomodulatory properties. Decreased serum vitamin D levels have been associated with clinical and MRI activity of MS. Løken-Amsrud et al. evaluated the association of retinol concentration with clinical and MRI measures of disease activity in MS patients over a 2-year period. Serum retinol levels correlated with MRI metrics of disease activity, but not with clinical findings. Following IFN-β-1a treatment, the association with MRI metrics was lost. These results support a role of vitamin A metabolites in influencing disease activity in MS.
Insights
Vitamin A metabolites, specifically serum retinol, may influence multiple sclerosis (MS) disease activity. Higher retinol levels correlated with MRI activity, but this link disappeared after interferon-beta treatment.
Area of Science:
- Neuroimmunology
- Nutritional Neuroscience
Background:
- Multiple sclerosis (MS) susceptibility involves genetic and environmental factors.
- Vitamin D and A metabolites possess immunomodulatory properties relevant to MS.
- Previous studies linked decreased vitamin D to MS activity.
Discussion:
- This study investigated the association between serum retinol concentration and MS disease activity over two years.
- Retinol levels showed a correlation with MRI-detected disease activity, but not clinical outcomes.
- The association between retinol and MRI activity was diminished after treatment with interferon-beta 1a (IFN-β-1a).
Key Insights:
- Serum retinol concentration is associated with subclinical disease activity in MS, as measured by MRI.
- The immunomodulatory role of vitamin A metabolites in MS may be influenced by treatment interventions.
- These findings highlight the potential impact of vitamin A metabolism on MS pathogenesis.
Outlook:
- Further research is warranted to elucidate the precise mechanisms by which vitamin A metabolites affect MS.
- Investigating vitamin A supplementation or modulation as a therapeutic strategy in MS could be beneficial.
- Understanding the interplay between vitamin A, immune responses, and MS progression is crucial for developing targeted therapies.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).

